Sign in
Active, not recruitingNo phase

Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

Key facts

Who runs it
EUROS
Where
France4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
120 people, planned
Started
27 Oct 2021
Expected to end
Jul 2032
Type of study
Observational
Treatments tested
  • Hip arthroplasty
Record updated
20 February 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Patient who received EUROSCUP Fixe
  • Patient informed of its participation to the study
  • Patient aged between 18 and 80 years old (<80)

Who cannot take part

  • Patient presenting a contraindication to EUROSCUP Fixe implantation
  • Patient who refused to participate to the study
  • Vulnerable subjects

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery.

Read full original descriptionShow less

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

The group in the trial

  • EUROSCUP Fixe

    120 patients who received EUROSCUP Fixe

    Treatment: Hip arthroplasty

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 February 2024